Epimedokoreanin BCAS# 161068-53-7 |
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
| Cas No. | 161068-53-7 | SDF | Download SDF |
| PubChem ID | 21147600 | Appearance | Yellow powder |
| Formula | C25H26O6 | M.Wt | 422.5 |
| Type of Compound | Flavonoids | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | 2-[3,4-dihydroxy-5-(3-methylbut-2-enyl)phenyl]-5,7-dihydroxy-8-(3-methylbut-2-enyl)chromen-4-one | ||
| SMILES | CC(=CCC1=C(C(=CC(=C1)C2=CC(=O)C3=C(O2)C(=C(C=C3O)O)CC=C(C)C)O)O)C | ||
| Standard InChIKey | QLZMBCVLWOJASJ-UHFFFAOYSA-N | ||
| Standard InChI | InChI=1S/C25H26O6/c1-13(2)5-7-15-9-16(10-21(29)24(15)30)22-12-20(28)23-19(27)11-18(26)17(25(23)31-22)8-6-14(3)4/h5-6,9-12,26-27,29-30H,7-8H2,1-4H3 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | 1. Epimedokoreanin B can significantly inhibit the formation of both N (ε) -(carboxymethyl)lysine (CML) and N (ω) -(carboxymethyl)arginine (CMA), it may prevent clinical complications of diabetes by inhibiting advanced glycation end-products (AGEs). 2. Epimedokoreanin B shows scavenge the DPPH radical activity. 3. Epimedokoreanin B can inhibit the proliferation of MCF-7 and HepG2 in dose-dependant manner. |
Epimedokoreanin B Dilution Calculator
Epimedokoreanin B Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 2.3669 mL | 11.8343 mL | 23.6686 mL | 47.3373 mL | 59.1716 mL |
| 5 mM | 0.4734 mL | 2.3669 mL | 4.7337 mL | 9.4675 mL | 11.8343 mL |
| 10 mM | 0.2367 mL | 1.1834 mL | 2.3669 mL | 4.7337 mL | 5.9172 mL |
| 50 mM | 0.0473 mL | 0.2367 mL | 0.4734 mL | 0.9467 mL | 1.1834 mL |
| 100 mM | 0.0237 mL | 0.1183 mL | 0.2367 mL | 0.4734 mL | 0.5917 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- VT-464
Catalog No.:BCC5398
CAS No.:1610537-15-9
- Hosenkoside M
Catalog No.:BCN4518
CAS No.:161016-51-9
- Dihydroperaksine
Catalog No.:BCN1713
CAS No.:16100-84-8
- TH588
Catalog No.:BCC6397
CAS No.:1609960-31-7
- TH287
Catalog No.:BCC6400
CAS No.:1609960-30-6
- Silodosin
Catalog No.:BCN2164
CAS No.:160970-54-7
- 2-[2-(2,2,2-Trifluoroethoxy)phenoxy]ethyl methanesulfonate
Catalog No.:BCN1546
CAS No.:160969-03-9
- 2-[2-(2,2,2-Trifluoroethoxy)phenoxy]ethyl bromide
Catalog No.:BCN1547
CAS No.:160969-00-6
- Mps1-IN-3
Catalog No.:BCC5496
CAS No.:1609584-72-6
- AZD3264
Catalog No.:BCC6514
CAS No.:1609281-86-8
- Villosin C
Catalog No.:BCN1712
CAS No.:160927-81-1
- Hosenkoside K
Catalog No.:BCN2577
CAS No.:160896-49-1
- Epimedokoreanin C
Catalog No.:BCN8080
CAS No.:161068-54-8
- Formyl-DL-Trp-OH
Catalog No.:BCC3120
CAS No.:16108-03-5
- Cimicifugoside H2
Catalog No.:BCN7949
CAS No.:161097-77-4
- Bidwillol A
Catalog No.:BCN4858
CAS No.:161099-42-9
- H-Asp(OEt)-OEt.HCl
Catalog No.:BCC2888
CAS No.:16115-68-7
- Cimicidanol 3-O-alpha-L-arabinoside
Catalog No.:BCN6528
CAS No.:161207-05-2
- H-Orn(Z)-OtBu.HCl
Catalog No.:BCC2677
CAS No.:161234-80-6
- SR-9243
Catalog No.:BCC3983
CAS No.:1613028-81-1
- 1-O-Acetyl-6-O-isobutyrylbritannilactone
Catalog No.:BCN7795
CAS No.:1613152-34-3
- Fmoc-Chg-OH
Catalog No.:BCC3164
CAS No.:161321-36-4
- SGC-CBP30
Catalog No.:BCC2419
CAS No.:1613695-14-9
- HTH-01-015
Catalog No.:BCC4010
CAS No.:1613724-42-7
[Comparison of antioxidative and antitumor activities of six flavonoids from Epimedium koreanum].[Pubmed:17608228]
Zhongguo Zhong Yao Za Zhi. 2007 Apr;32(8):715-8.
OBJECTIVE: To study the antioxidative and antitumor activities of flavonoids isolated from Epimedium koreanum. METHOD: The compounds were separated by column chromatography with silica gel and Sephadex LH-20, and identified by spectral a- nalysis (ESI-MS, 1H-NMR and 13C-NMR) respectively. DPPH radical scavenging assay and MTT assay were used to observe the antioxidative and antitumor abilities. RESULT: Six compounds were isolated from the the ethyl acetate extract of the aerial part. Their structures were identified as icariin (I), luteolin (II), baohuoside II (III), hyperoside (IV), Epimedokoreanin B (V) and baohuoside I (VI). The results indicated that at concentrations of 3. 125-200 micromol x L(-1), compound I, III and VI had no ability to scavenge the DPPH radical, but the scavenging ability of compounds II, IV and V were stronger than that of Vit C in dose-dependant manner. Compounds I, II, V and VI could inhibit the proliferation of MCF-7 and HepG2 in dose-dependant manner, but compounds III and IV had no effect on the proliferation. CONCLUSION: The antitumor activity of E. koreanum may be partially related to the antioxidantive activity of flavonoids.
Two new prenylflavonoids from Epimedii Herba and their inhibitory effects on advanced glycation end-products.[Pubmed:26758618]
J Nat Med. 2016 Apr;70(2):290-5.
Because inhibitors of advanced glycation end-products (AGEs), for example pyridoxamine, significantly inhibit the development of retinopathy and neuropathy in rats with streptozotocin-induced diabetes, treatment with AGE inhibitors is believed to be a potential strategy for the prevention of lifestyle-related diseases such as diabetic complications. In the present study, the MeOH extract of Epimedii Herba (EH; aerial parts of Epimedium spp.) was found to inhibit the formation of N (epsilon) -(carboxymethyl)lysine (CML) and N (omega) -(carboxymethyl)arginine (CMA) during incubation of collagen-derived gelatin with ribose. Furthermore, compounds with inhibitory effects against CML and CMA formation were isolated from EH. Two new prenylflavonoids (compounds 1 and 2) and two known compounds (3 and 4) were found to significantly inhibit the formation of both CML and CMA; compound 4 (Epimedokoreanin B) had the strongest inhibitory effect of the isolated compounds. These data suggest that Epimedokoreanin B could prevent clinical complications of diabetes by inhibiting AGEs.
